messages.author : Super Admin

Super Admin

Admin

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Praesent libero ligula, vestibulum ut justo sed.

By Super Admin

THEON receives a new order from a Northern European country for the thermal clip-on IRIS -C and swiftly converts soft backlog to hard backlog

PRESS RELEASE

IceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025

CAESAREA, Israel, July 3, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced...

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your...

Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results

JILIN, China, July 3, 2025 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in...

CNS Trials: Lessons in Adherence Monitoring from a Phase II Study, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how dose-by-dose adherence monitoring with digital tools and timely interventions can significantly increase patient retention and improve overall compliance in CNS trials. Attendees will gain insight into how active, daily adherence monitoring with a built-in...

Challenges and Opportunities in High Concentration Formulation Development and Delivery Systems for Subcutaneous Administration, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn about developing high-concentration, low-viscosity formulations and selecting the right delivery device for drugs. Attendees will gain insight into what goes in the development of drug delivery devices. The featured speakers will discuss how to accelerate...

Optimizing Drug Development: The Role of MIDD and PK/PD Modeling, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain insight into the FDA's perspective on model-informed drug development (MIDD). Attendees will learn about pharmacokinetic/pharmacodynamic (PK/PD) modeling strategies and their benefits. The featured speakers will discuss the application of PK/PD modeling and...

Obesity Clinical Trials: Beyond BMI, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn about the importance of moving beyond BMI to incorporate a range of biomarkers in clinical trials for obesity to enhance the accuracy of obesity diagnosis, facilitate precision medicine and improve the prevention and treatment of obesity-related diseases. The...

Xtalks Announces its Life Science Webinar Calendar for July 2025

Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, clinical trials, drug discovery & development and laboratory technology. TORONTO , July 3, 2025 /PRNewswire-PRWeb/ -- Stay on top of current hot topics through free webinars presented by leading experts in...

Form 8.5 (EPT/RI) - Dowlais Group plc

FORM 8.5 (EPT/RI)

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Organon To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Organon between October 31, 2024 and April 30, 2025 and would like to...

The Little Red Dog Launches July Fundraiser and Holiday Safety Tips

ORANGE COUNTY, Calif., July 3, 2025 /PRNewswire/ -- The Little Red Dog, a non-profit dog rescue, announced today its July fundraiser, a critical social media-driven campaign to combat surging euthanasia rates and dwindling donations. The organization is issuing an urgent call to action:...

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Civitas Resources

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Civitas To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Civitas between February 27, 2024 and February 24, 2025 and would like to...

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Compass Diversified

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Compass To Contact Him Directly To Discuss Their Options If you suffered purchased or acquired securities in Compass stock or options between May 1, 2024 and May 7, 2025 and...

Invitation to Vitrolife Group's presentation of the Q2 2025 interim report

GOTHENBURG, Sweden, July 3, 2025 /PRNewswire/ -- Vitrolife AB (publ) will publish its Q2 2025 interim report on Thursday, 17 July 2025 at 08:00 am CEST. A conference call for investors, analysts and financial media will be held at 10:00 am CEST the same day. The presentation will be held...